Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. iRadimed
IRMD

Buy iRadimed (IRMD) Stock

IRMD
See IRMD stock price and Buy/Sell iRadimed with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
IRMD

iRadimed (IRMD)

About iRadimed (IRMD)

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
Market Cap
$383.74M
1 Year High
$55.92
Volume
14.45k
1 Year Low
$28.18
Price to Earnings Ratio
31.63
Open
$30.20
Dividend Rate
High
$30.20
Dividend Yield
Low
$28.63

Community

People who own or watch IRMD stock

iRadimed Price Targets

What analysts think IRMD stock price will be.
$29.36
$42
43.1% Upside
$26$59

iRadimed Stock Rating

What analysts recommend for IRMD stock, on a scale from 1(buy) to 5(sell).
Strong Buy1 / 5
BuyHoldSell

iRadimed Stock Earnings

The value each IRMD share was expected to gain vs. the value that each IRMD share actually gained.
Expected
Actual

iRadimed Stock News

Frequently Asked Questions (FAQ)

As of Sep 28, 2022, the market cap for iRadimed stock is $383.74M

The current P/E ratio for iRadimed stock is 31.63

The 52-week high for iRadimed stock is $55.92. The current iRadimed stock price $29.36 is 47.50% below its 52-week high

The 52-week low for iRadimed stock is $28.18. The current iRadimed stock price $29.36 has increased 4.02% from its 52-week low

No, the iRadimed stock does not pay dividends to its shareholders

The target price for iRadimed stock is $42 based on the average of what a group of analyst think iRadimed stock could be worth at a future date. This is not a prediction by Public.com

Buy iRadimed (IRMD) Stock

IRMD
See IRMD stock price and Buy/Sell iRadimed with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch IRMD stock
  • gameover13 avatar
  • abdelmoaty avatar
  • shawnmtay avatar
  • madebychubb avatar
  • GBvito avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.